1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by RNA Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global RNA Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 siRNA
1.4.3 ASO
1.4.4 miRNA
1.4.5 Nucleic Acid Aptamers
1.5 Market by Application
1.5.1 Global RNA Drugs Market Share by Application: 2021-2026
1.5.2 Cancer
1.5.3 Diabetes
1.5.4 Tuberculosis
1.5.5 Cardiovascular Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global RNA Drugs Market
1.8.1 Global RNA Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global RNA Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global RNA Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global RNA Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers RNA Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global RNA Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global RNA Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America RNA Drugs Sales Volume
3.3.1 North America RNA Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia RNA Drugs Sales Volume
3.4.1 East Asia RNA Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe RNA Drugs Sales Volume (2015-2020)
3.5.1 Europe RNA Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia RNA Drugs Sales Volume (2015-2020)
3.6.1 South Asia RNA Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia RNA Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia RNA Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East RNA Drugs Sales Volume (2015-2020)
3.8.1 Middle East RNA Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa RNA Drugs Sales Volume (2015-2020)
3.9.1 Africa RNA Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania RNA Drugs Sales Volume (2015-2020)
3.10.1 Oceania RNA Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America RNA Drugs Sales Volume (2015-2020)
3.11.1 South America RNA Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World RNA Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World RNA Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World RNA Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America RNA Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia RNA Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe RNA Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia RNA Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia RNA Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East RNA Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa RNA Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania RNA Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America RNA Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World RNA Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global RNA Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global RNA Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global RNA Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global RNA Drugs Consumption Volume by Application (2015-2020)
15.2 Global RNA Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in RNA Drugs Business
16.1 Pfizer
16.1.1 Pfizer Company Profile
16.1.2 Pfizer RNA Drugs Product Specification
16.1.3 Pfizer RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Dicerna
16.2.1 Dicerna Company Profile
16.2.2 Dicerna RNA Drugs Product Specification
16.2.3 Dicerna RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Abbott Laboratories
16.3.1 Abbott Laboratories Company Profile
16.3.2 Abbott Laboratories RNA Drugs Product Specification
16.3.3 Abbott Laboratories RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Roche
16.4.1 Roche Company Profile
16.4.2 Roche RNA Drugs Product Specification
16.4.3 Roche RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Calimmune Inc
16.5.1 Calimmune Inc Company Profile
16.5.2 Calimmune Inc RNA Drugs Product Specification
16.5.3 Calimmune Inc RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Sanofi-Aventis
16.6.1 Sanofi-Aventis Company Profile
16.6.2 Sanofi-Aventis RNA Drugs Product Specification
16.6.3 Sanofi-Aventis RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Quark
16.7.1 Quark Company Profile
16.7.2 Quark RNA Drugs Product Specification
16.7.3 Quark RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Benitec Biopharma
16.8.1 Benitec Biopharma Company Profile
16.8.2 Benitec Biopharma RNA Drugs Product Specification
16.8.3 Benitec Biopharma RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Arrowhead Pharmaceuticals
16.9.1 Arrowhead Pharmaceuticals Company Profile
16.9.2 Arrowhead Pharmaceuticals RNA Drugs Product Specification
16.9.3 Arrowhead Pharmaceuticals RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Gradalis
16.10.1 Gradalis Company Profile
16.10.2 Gradalis RNA Drugs Product Specification
16.10.3 Gradalis RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Tekmira
16.11.1 Tekmira Company Profile
16.11.2 Tekmira RNA Drugs Product Specification
16.11.3 Tekmira RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 RXi
16.12.1 RXi Company Profile
16.12.2 RXi RNA Drugs Product Specification
16.12.3 RXi RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Alnylam Pharmaceuticals
16.13.1 Alnylam Pharmaceuticals Company Profile
16.13.2 Alnylam Pharmaceuticals RNA Drugs Product Specification
16.13.3 Alnylam Pharmaceuticals RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Silenseed
16.14.1 Silenseed Company Profile
16.14.2 Silenseed RNA Drugs Product Specification
16.14.3 Silenseed RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Senesco
16.15.1 Senesco Company Profile
16.15.2 Senesco RNA Drugs Product Specification
16.15.3 Senesco RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Silence Therapeutics
16.16.1 Silence Therapeutics Company Profile
16.16.2 Silence Therapeutics RNA Drugs Product Specification
16.16.3 Silence Therapeutics RNA Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 RNA Drugs Manufacturing Cost Analysis
17.1 RNA Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of RNA Drugs
17.4 RNA Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 RNA Drugs Distributors List
18.3 RNA Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of RNA Drugs (2021-2026)
20.2 Global Forecasted Revenue of RNA Drugs (2021-2026)
20.3 Global Forecasted Price of RNA Drugs (2015-2026)
20.4 Global Forecasted Production of RNA Drugs by Region (2021-2026)
20.4.1 North America RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America RNA Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World RNA Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of RNA Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of RNA Drugs by Country
21.2 East Asia Market Forecasted Consumption of RNA Drugs by Country
21.3 Europe Market Forecasted Consumption of RNA Drugs by Countriy
21.4 South Asia Forecasted Consumption of RNA Drugs by Country
21.5 Southeast Asia Forecasted Consumption of RNA Drugs by Country
21.6 Middle East Forecasted Consumption of RNA Drugs by Country
21.7 Africa Forecasted Consumption of RNA Drugs by Country
21.8 Oceania Forecasted Consumption of RNA Drugs by Country
21.9 South America Forecasted Consumption of RNA Drugs by Country
21.10 Rest of the world Forecasted Consumption of RNA Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer